Dr. Michael Paul Skolka, MD

Dr. Skolka practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Skolka's NPI, 1134610199, was assigned on May 25, 2018. Dr. Skolka graduated from Penn State College of Medicine in 2018. Dr. Skolka holds Minnesota license 66050.

Dr. Skolka's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Skolka's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. Dr. Skolka is also affiliated with Mayo Clinic Hospital. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Skolka to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Skolka practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Skolka's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Skolka is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Skolka's licenses on file in 3 states: Minnesota, Florida and Pennsylvania.

Dmand AI lists lower back pain, muscle disease and neuropathy among the conditions Dr. Skolka treats.

CMS data shows 327 Medicare services from Dr. Skolka across 11 procedure codes in 2024, for 169 Medicare patients. Medicare paid $22,164 for them.

CMS counts 169 Medicare patients who saw Dr. Skolka in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high cholesterol, and 71% have arthritis. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Skolka's median patient age at 59, with 52% women.

In 2024, Dr. Skolka wrote 31 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $242 in total drug cost. In 2023, CMS named 19 claims across 1 drug.

Dr. Skolka accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Skolka as offering telehealth.

Dmand AI links 30 papers to Dr. Skolka, published from 2004 to 2025. 2023 was the busiest year, with 5. The most frequent topics are Electromyography, Autoantibodies and Muscle, Skeletal. Dr. Skolka has published most often in Medicine (Baltimore). Dr. Skolka's most frequent co-authors are Christopher J. Klein, MD, Devon I. Rubin, MD and Divyanshu Dubey.

CMS Open Payments shows 1 general payment to Dr. Skolka from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Cadwell Industries, INC paid the most, $158.

Dr. Skolka graduated from Penn State College of Medicine in 2018.

Dr. Skolka is in network with 5 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.